AstraZeneca to acquire CinCor to boost its heart and kidney businessLeigh Mc Gowranon January 9, 2023 at 14:29 Silicon RepublicSilicon Republic

0

The pharma giant said CinCor’s drug could be combined with its own product – Farxiga – to help treat issues such as chronic kidney disease.

Read more: AstraZeneca to acquire CinCor to boost its heart and kidney business

Leave a Comment

Generated by Feedzy